Tvardi Therapeutics (TVRD) Share-based Compensation (IS) (2024 - 2026)
Tvardi Therapeutics' Share-based Compensation (IS) came in at $335,000 for Q2 2026, down 46.6% from $627,000 a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tvardi Therapeutics reported Share-based Compensation (IS) of $1.4 million, up 61.3% year-over-year; for FY2025, it came in at $1.4 million, up 338.6% from FY2024.
- Going back by year, Share-based Compensation (IS) was $319,000 in FY2024.
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation (IS) since Q1 2025.
- Year-over-year, Share-based Compensation (IS) increased in four of the last five quarters, with growth averaging 336.0%.
- Business Quant data shows TVRD's Share-based Compensation (IS) at $370,000 (Q1 2026), $353,000 (Q4 2025) and $339,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | 335,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 335,000.00 |
| Mar 31, 2026 | 370,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 627,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 79,000.00 |
API Access
Tvardi Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();